Mood-stabilizing drugs: Are their neuroprotective aspects clinically relevant?

Psychiatric Clinics of North America

Volumn 28, Issue 2, 2005, Pages 399-414

  Lagace, Diane C ^a   Eisch, Amelia J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; PLACEBO; VALPROIC ACID;

BIPOLAR DISORDER; BRAIN REGION; CELL CULTURE; DIAGNOSTIC IMAGING; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; GABAERGIC SYSTEM; HUMAN; IN VITRO STUDY; MEDICAL ASSESSMENT; MEDICAL RESEARCH; MONOTHERAPY; MOOD DISORDER; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

EID: 17044418832     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2005.02.002     Document Type: Review

References (102)

1. H.K. Manji, G.J. Moore, and G. Chen Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? Biol Psychiatry 46 7 1999 929 940
2. J. Cade Lithium salts in the treatment of psychotic symptoms Med J Aust 36 1949 349 352
3. R.C. Kessler, K.A. McGonagle, and S. Zhao Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey Arch Gen Psychiatry 51 1 1994 8 19
4. M.M. Weissman, R.C. Bland, and G.J. Canino Cross-national epidemiology of major depression and bipolar disorder JAMA 276 4 1996 293 299
5. R.M. Hirschfeld, and L.A. Vornik Recognition and diagnosis of bipolar disorder J Clin Psychiatry 65 Suppl 15 2004 5 9
6. C. Lennkh, and C. Simhandl Current aspects of valproate in bipolar disorder Int Clin Psychopharmacol 15 1 2000 1 11
7. L.N. Yatham Newer anticonvulsants in the treatment of bipolar disorder J Clin Psychiatry 65 Suppl 10 2004 28 35
8. A.F. Schatzberg Employing pharmacologic treatment of bipolar disorder to greatest effect J Clin Psychiatry 65 Suppl 15 2004 15 20
9. E.J. Nestler, E. Gould, and H. Manji Preclinical models: status of basic research in depression Biol Psychiatry 52 6 2002 503 528
10. H.K. Manji, G.J. Moore, and G. Chen Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness Biol Psychiatry 48 8 2000 740 754
11. N. Brunello Mood stabilizers: protecting the mood, protecting the brain J Affect Disord 79 Suppl 1 2004 S15 S20
12. M.K. Rowe, and D.M. Chuang Lithium neuroprotection: molecular mechanisms and clinical implications Expert Rev Mol Med 6 21 2004 1 18
13. G. Rajkowska Cell pathology in mood disorders Semin Clin Neuropsychiatry 7 4 2002 281 292
14. A.J. Eisch Adult neurogenesis: implications for psychiatry Prog Brain Res 138 2002 315 342
15. J.T. Coyle, and R.S. Duman Finding the intracellular signaling pathways affected by mood disorder treatments Neuron 38 2 2003 157 160
16. M. Bauer, M. Alda, and J. Priller Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders Pharmacopsychiatry 36 Suppl 3 2003 S250 S254
17. X. Li, T.A. Ketter, and M.A. Frye Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders? J Affect Disord 69 1-3 2002 1 14
18. J.A. Quiroz, J. Singh, and T.D. Gould Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology Mol Psychiatry 9 8 2004 756 776
19. T.D. Gould, J.A. Quiroz, and J. Singh Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers Mol Psychiatry 9 8 2004 734 755
20. + Eur J Biochem 266 3 1999 886 891
21. R.B. Sassi, M. Nicoletti, and P. Brambilla Increased gray matter volume in lithium-treated bipolar disorder patients Neurosci Lett 329 2 2002 243 245
22. S.M. Strakowski, M.P. Delbello, and C.M. Adler The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings Mol Psychiatry 10 1 2005 105 116
23. C.D. Bown, J.F. Wang, and L.T. Young Attenuation of N-methyl-D-aspartate- mediated cytoplasmic vacuolization in primary rat hippocampal neurons by mood stabilizers Neuroscience 117 4 2003 949 955
24. G. Chen, G. Rajkowska, and F. Du Enhancement of hippocampal neurogenesis by lithium J Neurochem 75 4 2000 1729 1734
25. Y. Hao, T. Creson, and L. Zhang Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis J Neurosci 24 29 2004 6590 6599
26. J.S. Kim, M.Y. Chang, and I.T. Yu Lithium selectively increases neuronal differentiation of hippocampal neural progenitor cells both in vitro and in vivo J Neurochem 89 2 2004 324 336
27. R.S. Williams, L. Cheng, and A.W. Mudge A common mechanism of action for three mood-stabilizing drugs Nature 417 6886 2002 292 295
28. G.E. Wood, L.T. Young, and L.P. Reagan Stress-induced structural remodeling in hippocampus: prevention by lithium treatment Proc Natl Acad Sci U S A 101 11 2004 3973 3978
29. K.L. Kopnisky, E. Chalecka-Franaszek, and M. Gonzalez-Zulueta Chronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatase 1 and increasing MEK activities Neuroscience 116 2 2003 425 435
30. R. Hashimoto, C. Hough, and T. Nakazawa Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation J Neurochem 80 4 2002 589 597
31. S. Nonaka, N. Katsube, and D.M. Chuang Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine J Pharmacol Exp Ther 286 1 1998 539 547
32. S. Grignon, N. Levy, and F. Couraud Tyrosine kinase inhibitors and cycloheximide inhibit Li + protection of cerebellar granule neurons switched to non-depolarizing medium Eur J Pharmacol 315 1 1996 111 114
33. R. Li, and R.S. El-Mallahk A novel evidence of different mechanisms of lithium and valproate neuroprotective action on human SY5Y neuroblastoma cells: caspase-3 dependency Neurosci Lett 294 3 2000 147 150
34. P.X. Yuan, L.D. Huang, and Y.M. Jiang The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth J Biol Chem 276 34 2001 31674 31683
35. X. Li, G.N. Bijur, and R.S. Jope Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection Bipolar Disord 4 2 2002 137 144
36. E.G. Jorda, E. Verdaguer, and A. Morano Lithium prevents colchicine-induced apoptosis in rat cerebellar granule neurons Bipolar Disord 6 2 2004 144 149
37. G.N. Bijur, P. De Sarno, and R.S. Jope Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium J Biol Chem 275 11 2000 7583 7590
38. H. Wei, P.R. Leeds, and Y. Qian Beta-amyloid peptide-induced death of PC 12 cells and cerebellar granule cell neurons is inhibited by long-term lithium treatment Eur J Pharmacol 392 3 2000 117 123
39. Peng G, Li G, Tzeng N, et al. Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat midbrain cultures: role of microglia. Brain Res Mol Brain Res, in press.
40. R. Pardo, A.G. Andreolotti, and B. Ramos Opposed effects of lithium on the MEK-ERK pathway in neural cells: inhibition in astrocytes and stimulation in neurons by GSK3 independent mechanisms J Neurochem 87 2 2003 417 426
41. L. Song, T. Zhou, and R.S. Jope Lithium facilitates apoptotic signaling induced by activation of the Fas death domain-containing receptor BMC Neurosci 5 1 2004 20
42. J.P. Hennion, M.A. el-Masri, and M.O. Huff Evaluation of neuroprotection by lithium and valproic acid against ouabain-induced cell damage Bipolar Disord 4 3 2002 201 206
43. E.D. Daniel, A.W. Mudge, and P.R. Maycox Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons Bipolar Disord 7 1 2005 33 41
44. R. Williams, W.J. Ryves, and E.C. Dalton A molecular cell biology of lithium Biochem Soc Trans 32 Pt 5 2004 799 802
45. R. Hashimoto, V. Senatorov, and H. Kanai Lithium stimulates progenitor proliferation in cultured brain neurons Neuroscience 117 1 2003 55 61
46. A. Shimomura, R. Nomura, and T. Senda Lithium inhibits apoptosis of mouse neural progenitor cells Neuroreport 14 14 2003 1779 1782
47. P. Laeng, R.L. Pitts, and A.L. Lemire The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells J Neurochem 91 1 2004 238 251
48. C.J. Murray, and A.D. Lopez Evidence-based health policy-lessons from the Global Burden of Disease Study Science 274 5288 1996 740 743
49. Practice guideline for the treatment of patients with bipolar disorder (revision) Am J Psychiatry 159 4 Suppl 2002 1 50
50. H. Einat, H.K. Manji, and R.H. Belmaker New approaches to modeling bipolar disorder Psychopharmacol Bull 37 1 2003 47 63
51. R. Machado-Vieira, F. Kapczinski, and J.C. Soares Perspectives for the development of animal models of bipolar disorder Prog Neuropsychopharmacol Biol Psychiatry 28 2 2004 209 224
52. E.J. Nestler, M. Barrot, and R.J. DiLeone Neurobiology of depression Neuron 34 1 2002 13 25
53. R. Machado-Vieira, A.P. Schmidt, and T.T. Avila Increased cerebrospinal fluid levels of S100B protein in rat model of mania induced by ouabain Life Sci 76 7 2004 805 811
54. R.S. el-Mallakh, L.T. Harrison, and R. Li An animal model for mania: preliminary results Prog Neuropsychopharmacol Biol Psychiatry 19 5 1995 955 962
55. R. Li, R.S. el-Mallakh, L. Harrison, and D.G. Changaris Lithium prevents ouabain-induced behavioral changes. Toward an animal model for manic depression Mol Chem Neuropathol 31 1 1997 65 72
56. Q. Wei, X.Y. Lu, and L. Liu Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability Proc Natl Acad Sci U S A 101 32 2004 11851 11856
57. O.C. Ikonomov, T. Petrov, and K. Soden Lithium treatment in ovo: effects on embryonic heart rate, natural death of ciliary ganglion neurons, and brain expression of a highly conserved chicken homolog of human MTG8/ETO Brain Res Dev Brain Res 123 1 2000 13 24
58. S.S. Cui, C.P. Yang, and R.C. Bowen Valproic acid enhances axonal regeneration and recovery of motor function after sciatic nerve axotomy in adult rats Brain Res 975 1-2 2003 229 236
59. M.B. Youdim, and Z. Arraf Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax Neuropharmacology 46 8 2004 1130 1140
60. O. Ghribi, M.M. Herman, and J. Savory Lithium inhibits Abeta-induced stress in endoplasmic reticulum of rabbit hippocampus but does not prevent oxidative damage and tau phosphorylation J Neurosci Res 71 6 2003 853 862
61. H. Wei, Z.H. Qin, and V.V. Senatorov Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease Neuroscience 106 3 2001 603 612
62. H.L. Edmonds Jr., Y.D. Jiang, and P.Y. Zhang Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration Life Sci 69 19 2001 2265 2277
63. S. Nonaka, and D.M. Chuang Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats Neuroreport 9 9 1998 2081 2084
64. J. Xu, J. Culman, and A. Blume Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death Stroke 34 5 2003 1287 1292
65. M. Ren, V.V. Senatorov, and R.W. Chen Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model Proc Natl Acad Sci U S A 100 10 2003 6210 6215
66. J. Ma, G.Y. Zhang, and Y. Liu Lithium suppressed Tyr-402 phosphorylation of proline-rich tyrosine kinase (Pyk2) and interactions of Pyk2 and PSD-95 with NR2A in rat hippocampus following cerebral ischemia Neurosci Res 49 4 2004 357 362
67. H. Son, I.T. Yu, and S.J. Hwang Lithium enhances long-term potentiation independently of hippocampal neurogenesis in the rat dentate gyrus J Neurochem 85 4 2003 872 881
68. J.E. Malberg, A.J. Eisch, and E.J. Nestler Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus J Neurosci 20 24 2000 9104 9110
69. I.T. Yu, J.S. Kim, and S.H. Lee Chronic lithium enhances hippocampal long-term potentiation, but not neurogenesis, in the aged rat dentate gyrus Biochem Biophys Res Commun 303 4 2003 1193 1198
70. M. Sairanen, G. Lucas, and P. Ernfors Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus J Neurosci 25 5 2005 1089 1094
71. L. Santarelli, M. Saxe, and C. Gross Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants Science 301 5634 2003 805 809
72. J.E. Malberg, and R.S. Duman Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment Neuropsychopharmacology 28 9 2003 1562 1571
73. B. Vollmayr, C. Simonis, and S. Weber Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness Biol Psychiatry 54 10 2003 1035 1040
74. H.E. Scharfman Functional implications of seizure-induced neurogenesis Adv Exp Med Biol 548 2004 192 212
75. M. Haldane, and S. Frangou New insights help define the pathophysiology of bipolar affective disorder: neuroimaging and neuropathology findings Prog Neuropsychopharmacol Biol Psychiatry 28 6 2004 943 960
76. J.L. Beyer, and K.R. Krishnan Volumetric brain imaging findings in mood disorders Bipolar Disord 4 2 2002 89 104
77. G.J. Moore, J.M. Bebchuk, and I.B. Wilds Lithium-induced increase in human brain grey matter Lancet 356 9237 2000 1241 1242
78. T. Kieseppa, T.G. van Erp, and J. Haukka Reduced left hemispheric white matter volume in twins with bipolar I disorder Biol Psychiatry 54 9 2003 896 905
79. R.B. Sassi, P. Brambilla, and J.P. Hatch Reduced left anterior cingulate volumes in untreated bipolar patients Biol Psychiatry 56 7 2004 467 475
80. T.E. Schlaepfer, G.J. Harris, and A.Y. Tien Decreased regional cortical gray matter volume in schizophrenia Am J Psychiatry 151 6 1994 842 848
81. R.B. Zipursky, M.V. Seeman, and A. Bury Deficits in gray matter volume are present in schizophrenia but not bipolar disorder Schizophr Res 26 2-3 1997 85 92
82. S.M. Strakowski, D.R. Wilson, and M. Tohen Structural brain abnormalities in first-episode mania Biol Psychiatry 33 8-9 1993 602 609
83. I. Harvey, R. Persaud, and M.A. Ron Volumetric MRI measurements in bipolars compared with schizophrenics and healthy controls Psychol Med 24 3 1994 689 699
84. R.M. Dupont, T.L. Jernigan, and W. Heindel Magnetic resonance imaging and mood disorders. Localization of white matter and other subcortical abnormalities Arch Gen Psychiatry 52 9 1995 747 755
85. G.D. Pearlson, P.E. Barta, and R.E. Powers Ziskind-Somerfeld Research Award 1996. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder Biol Psychiatry 41 1 1997 1 14
86. P. Brambilla, K. Harenski, and M. Nicoletti Differential effects of age on brain gray matter in bipolar patients and healthy individuals Neuropsychobiology 43 4 2001 242 247
87. M.P. Lopez-Larson, M.P. DelBello, and M.E. Zimmerman Regional prefrontal gray and white matter abnormalities in bipolar disorder Biol Psychiatry 52 2 2002 93 100
88. K.A. Davis, A. Kwon, and V.A. Cardenas Decreased cortical gray and cerebral white matter in male patients with familial bipolar I disorder J Affect Disord 82 3 2004 475 485
89. K.O. Lim, M.J. Rosenbloom, and W.O. Faustman Cortical gray matter deficit in patients with bipolar disorder Schizophr Res 40 3 1999 219 227
90. A. Doris, E. Belton, and K.P. Ebmeier Reduction of cingulate gray matter density in poor outcome bipolar illness Psychiatry Res 130 2 2004 153 159
91. S.M. Strakowski, M.P. DelBello, and K.W. Sax Brain magnetic resonance imaging of structural abnormalities in bipolar disorder Arch Gen Psychiatry 56 3 1999 254 260
92. W.C. Drevets, J.L. Price, and J.R. Simpson Jr. Subgenual prefrontal cortex abnormalities in mood disorders Nature 386 6627 1997 824 827
93. Y. Hirayasu, M.E. Shenton, and D.F. Salisbury Subgenual cingulate cortex volume in first-episode psychosis Am J Psychiatry 156 7 1999 1091 1093
94. S. Frangou, M. Hadjulis, and X. Chitnis The Maudsley Bipolar Disorder Project: brain structural changes in bipolar I disorder Bipolar Disord 4 2002 123 124
95. D. Ongur, W.C. Drevets, and J.L. Price Glial reduction in the subgenual prefrontal cortex in mood disorders Proc Natl Acad Sci U S A 95 22 1998 13290 13295
96. G. Rajkowska, A. Halaris, and L.D. Selemon Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder Biol Psychiatry 49 9 2001 741 752
97. F.M. Benes, S.L. Vincent, and M. Todtenkopf The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects Biol Psychiatry 50 6 2001 395 406
98. F.M. Benes, E.W. Kwok, and S.L. Vincent A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives Biol Psychiatry 44 2 1998 88 97
99. B. Baumann, P. Danos, and D. Krell Unipolar-bipolar dichotomy of mood disorders is supported by noradrenergic brainstem system morphology J Affect Disord 54 1-2 1999 217 224
100. M.P. Bowley, W.C. Drevets, and D. Ongur Low glial numbers in the amygdala in major depressive disorder Biol Psychiatry 52 2002 404 412
101. C.L. Bowden Making optimal use of combination pharmacotherapy in bipolar disorder J Clin Psychiatry 65 Suppl 15 2004 21 24
102. R. Lingam, and J. Scott Treatment non-adherence in affective disorders Acta Psychiatr Scand 105 3 2002 164 172